BIOX
BIOX
NASDAQ · Chemicals

Bioceres Crop Solutions Corp

$0.36
-0.02 (-4.35%)
As of Sep 28, 10:33 PM ET ·
Financial Highlights (FY 2026)
Revenue
230.04M
Net Income
-222,786,123
Gross Margin
34.6%
Profit Margin
-96.9%
Rev Growth
-17.0%
D/E Ratio
6.06
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 34.6% 34.6% 35.4% 35.4%
Operating Margin -0.1% -0.1% 15.8% 13.1%
Profit Margin -96.9% -92.0% 12.8% 14.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 230.04M 276.99M 10.13M 10.46M
Gross Profit 79.71M 95.98M 3.59M 3.71M
Operating Income -184,031 -199,431 1.61M 1.37M
Net Income -222,786,123 -241,429,874 1.30M 1.47M
Gross Margin 34.6% 34.6% 35.4% 35.4%
Operating Margin -0.1% -0.1% 15.8% 13.1%
Profit Margin -96.9% -92.0% 12.8% 14.0%
Rev Growth -17.0% -17.0% +24.0% +22.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 9.80M 9.80M 7.53M 9.76M
Total Equity 1.62M 1.62M 24.77M 27.77M
D/E Ratio 6.06 6.06 0.30 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 22.48M 25.72M 2.20M 2.21M
Free Cash Flow — — 1.19M 1.17M